Cheri Walker

Cheri Walker

Directeur/Bestuurslid bij ATOMO DIAGNOSTICS LIMITED
Commercial Services
Health Technology
Finance

Profiel

Cheri L.
Walker
is currently Chief Executive Officer at Zeta Corp, Non-Executive Director at Atomo Diagnostics Ltd. since 2022, and Director at Cell IDx, Inc. Former positions include President, Chief Executive Officer & Director at Rhinostics, Inc. from 2020 to 2023; Vice President at Invitrogen Corp.; Analyst at Deutsche Bank Securities, Inc. from 2003 to 2005; Senior Vice President-Corporate Development and Senior Vice President at Charles River Laboratories International, Inc. and Charles River Laboratories, Inc.; Chief Commercial Officer at SeraCare Life Sciences, Inc.; Operating Executive at SFW Capital Partners LP; Vice President-Mergers & Acquisition at Qiagen, Inc. and QIAGEN Sciences, Inc.; and Vice President at Proteomics, Inc. Education includes undergraduate studies at Swarthmore College and a doctorate from Baylor College of Medicine.

Actieve functies van Cheri Walker

BedrijvenFunctieBegin
ATOMO DIAGNOSTICS LIMITED Directeur/Bestuurslid 15-11-2022
Directeur/Bestuurslid -
Algemeen Directeur -

Eerdere bekende functies van Cheri Walker

BedrijvenFunctieEinde
Algemeen Directeur 01-11-2023
Analyst-Equity 28-07-2005
Corporate Officer/Principal -
Corporate Officer/Principal -
Proteomics, Inc.
Corporate Officer/Principal -
Ervaring van Cheri Walker in detail bekijken

Opleiding van Cheri Walker

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

96

Eerstegraads connecties

15

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit15

Electronic Technology

Finance

Commercial Services

Commercial Services

Health Technology

Consumer Services

Consumer Services

Finance

Commercial Services

Process Industries

Proteomics, Inc.

Health Technology

Commercial Services

Commercial Services

Health Technology

  1. Beurs
  2. Insiders
  3. Cheri Walker